- S K Obaro, honorary lecturer in paediatric immunologya,
- M A Monteil, senior clinical lecturera,
- D C Henderson, principal immunologista
- a Department of Immunology, Charing Cross and Westminster Medical School, Chelsea and Westminster Hospital, London SW10 9NH
- Correspondence to: Dr Henderson.
- Accepted 24 April 1996
Abstract
Summary points
Mortality from bacteraemic pneumonia has remained unchanged at 25% over the last 40 years
Globally, Streptococcus pneumoniae causes over 1 million deaths in children under the age of 5 years
Antibiotic resistant strains of S pneumoniae are increasing world wide. In Spain over 50% of isolates are resistant to one or more antibiotics
Patients at increased risk of severe pneumococcal infection should be:
Footnotes
- Accepted 24 April 1996
Sign in
Personal subscribers, sign in here:
Article access
Article access for 1 day
Purchase this article for £20 $30 €32*
The PDF version can be downloaded as your personal record
CiteULike
Connotea
Del.icio.us
Digg
Facebook
Reddit
Technorati
Twitter
Stumbleupon
Rapid responses
Latest Responses
The decline in the breast cancer incidence is 1.2% and it is not significant.
Published 10 February 2012
'twas ever thus
Published 10 February 2012
The value of historic human remains
Published 10 February 2012
In Praise of British Literature
Published 10 February 2012
Is real shared decision making possible?
Published 10 February 2012
Most responses
Does anyone understand the government’s plan for the NHS? (17 responses)
Published 17 Jan 2012
Bad medicine: medical nutrition (15 responses)
Published 18 Jan 2012
Shared decision making: really putting patients at the centre of healthcare (7 responses)
Published 27 Jan 2012
Why legislation is necessary for my health reforms (7 responses)
Published 1 Feb 2012
Search for evidence goes on (5 responses)
Published 17 Jan 2012